J9050 Injection, carmustine, 100 mg

BackJ9000Injection, doxorubicin hydrochloride, 10 mgJ9003Leuprolide injectable (camcevi etm), 1 mgJ9011Injection, datopotamab deruxtecan-dlnk, 1 mgJ9015Injection, aldesleukin, per single use vialJ9017Injection, arsenic trioxide, 1 mgJ9021Injection, asparaginase, recombinant, (rylaze), 0.1 mgJ9022Injection, atezolizumab, 10 mgJ9023Injection, avelumab, 10 mgJ9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjsJ9025Injection, azacitidine, 1 mgJ9026Injection, tarlatamab-dlle, 1 mgJ9027Injection, clofarabine, 1 mgJ9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramJ9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic doseJ9030Bcg live intravesical instillation, 1 mgJ9032Injection, belinostat, 10 mgJ9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mgJ9034Injection, bendamustine hcl (bendeka), 1 mgJ9035Injection, bevacizumab, 10 mgJ9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mgJ9038Injection, axatilimab-csfr, 0.1 mgJ9039Injection, blinatumomab, 1 microgramJ9040Injection, bleomycin sulfate, 15 unitsJ9041Injection, bortezomib, 0.1 mgJ9042Injection, brentuximab vedotin, 1 mgJ9043Injection, cabazitaxel, 1 mgJ9045Injection, carboplatin, 50 mgJ9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mgJ9047Injection, carfilzomib, 1 mgJ9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mgJ9049Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mgJ9050Injection, carmustine, 100 mgJ9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mgJ9052Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mgJ9053Injection, belantamab mafodotin-blmf, 0.1 mgJ9054Injection, bortezomib (boruzu), 0.1 mgJ9055Injection, cetuximab, 10 mgJ9056Injection, bendamustine hydrochloride (vivimusta), 1 mgJ9057Injection, copanlisib, 1 mgJ9060Injection, cisplatin, powder or solution, 10 mgJ9061Injection, amivantamab-vmjw, 2 mgJ9062Injection, amivantamab 5 mg and hyaluronidase-lpujJ9063Injection, mirvetuximab soravtansine-gynx, 1 mgJ9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mgJ9065Injection, cladribine, per 1 mgJ9066Injection, bendamustine hydrochloride (avyxa), 1 mgJ9071Injection, cyclophosphamide (auromedics), 5 mgJ9072Injection, cyclophosphamide (frindovyx), 5 mgJ9073Injection, cyclophosphamide (dr. reddy's), 5 mgJ9074Injection, cyclophosphamide (sandoz), 5 mgJ9075Injection, cyclophosphamide, not otherwise specified, 5 mgJ9076Injection, cyclophosphamide (baxter), 5 mgJ9100Injection, cytarabine, 100 mgJ9118Injection, calaspargase pegol-mknl, 10 unitsJ9119Injection, cemiplimab-rwlc, 1 mgJ9120Injection, dactinomycin, 0.5 mgJ9130Dacarbazine, 100 mgJ9144Injection, daratumumab, 10 mg and hyaluronidase-fihjJ9145Injection, daratumumab, 10 mgJ9150Injection, daunorubicin, 10 mgJ9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabineJ9155Injection, degarelix, 1 mgJ9161Injection, denileukin diftitox-cxdl, 1 mcgJ9171Injection, docetaxel, 1 mgJ9172Injection, docetaxel (docivyx), 1 mgJ9173Injection, durvalumab, 10 mgJ9174Injection, docetaxel (beizray), 1 mgJ9175Injection, elliotts' b solution, 1 mlJ9176Injection, elotuzumab, 1 mgJ9177Injection, enfortumab vedotin-ejfv, 0.25 mgJ9178Injection, epirubicin hcl, 2 mgJ9179Injection, eribulin mesylate, 0.1 mgJ9183Gemcitabine intravesical system, 225 mgJ9184Injection, gemcitabine hydrochloride (avyxa), 200 mgJ9185Injection, fludarabine phosphate, 50 mgJ9186Injection, etoposide (avyxa), 1 mgJ9187Injection, etoposide, 1 mgJ9191Injection, fluorouracil (avyxa), 10 mgJ9192Injection, fluorouracil, 10 mgJ9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mgJ9198Injection, gemcitabine hydrochloride, (infugem), 100 mgJ9200Injection, floxuridine, 500 mgJ9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mgJ9202Goserelin acetate implant, per 3.6 mgJ9203Injection, gemtuzumab ozogamicin, 0.1 mgJ9204Injection, mogamulizumab-kpkc, 1 mgJ9205Injection, irinotecan liposome, 1 mgJ9206Injection, irinotecan, 20 mgJ9207Injection, ixabepilone, 1 mgJ9208Injection, ifosfamide, 1 gramJ9209Injection, mesna, 200 mgJ9210Injection, emapalumab-lzsg, 1 mgJ9211Injection, idarubicin hydrochloride, 5 mgJ9213Injection, interferon, alfa-2a, recombinant, 3 million unitsJ9214Injection, interferon, alfa-2b, recombinant, 1 million unitsJ9215Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iuJ9216Injection, interferon, gamma 1-b, 3 million unitsJ9217Leuprolide acetate (for depot suspension), 7.5 mgJ9218Leuprolide acetate, per 1 mgJ9219Leuprolide acetate implant, 65 mgJ9220Injection, indigotindisulfonate sodium, 1 mgJ9223Injection, lurbinectedin, 0.1 mgJ9225Histrelin implant (vantas), 50 mgJ9226Histrelin implant (supprelin la), 50 mgJ9227Injection, isatuximab-irfc, 10 mgJ9228Injection, ipilimumab, 1 mgJ9229Injection, inotuzumab ozogamicin, 0.1 mgJ9230Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mgJ9232Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mgJ9245Injection, melphalan hydrochloride, not otherwise specified, 50 mgJ9246Injection, melphalan (evomela), 1 mgJ9248Injection, melphalan (hepzato), 1 mgJ9249Injection, melphalan (apotex), 1 mgJ9255Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mgJ9256Injection, nipocalimab-aahu, 3 mgJ9260Injection, methotrexate sodium, 50 mgJ9261Injection, nelarabine, 50 mgJ9262Injection, omacetaxine mepesuccinate, 0.01 mgJ9263Injection, oxaliplatin, 0.5 mgJ9264Injection, paclitaxel protein-bound particles, 1 mgJ9266Injection, pegaspargase, per single dose vialJ9267Injection, paclitaxel, 1 mgJ9268Injection, pentostatin, 10 mgJ9269Injection, tagraxofusp-erzs, 10 microgramsJ9271Injection, pembrolizumab, 1 mgJ9272Injection, dostarlimab-gxly, 10 mgJ9273Injection, tisotumab vedotin-tftv, 1 mgJ9274Injection, tebentafusp-tebn, 1 microgramJ9275Injection, cosibelimab-ipdl, 2 mgJ9276Injection, zanidatamab-hrii, 2 mgJ9277Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmphJ9278Injection, carboplatin (avyxa), 1 mgJ9280Injection, mitomycin, 5 mgJ9281Mitomycin pyelocalyceal instillation, 1 mgJ9282Mitomycin, intravesical instillation, 1 mgJ9285Injection, olaratumab, 10 mgJ9286Injection, glofitamab-gxbm, 2.5 mgJ9289Injection, nivolumab, 2 mg and hyaluronidase-nvhyJ9292Injection, pemetrexed dipotassium, 10 mgJ9293Injection, mitoxantrone hydrochloride, per 5 mgJ9294Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mgJ9295Injection, necitumumab, 1 mgJ9296Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mgJ9297Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mgJ9298Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mgJ9299Injection, nivolumab, 1 mgJ9301Injection, obinutuzumab, 10 mgJ9302Injection, ofatumumab, 10 mgJ9303Injection, panitumumab, 10 mgJ9304Injection, pemetrexed (pemfexy), 10 mgJ9305Injection, pemetrexed, not otherwise specified, 10 mgJ9306Injection, pertuzumab, 1 mgJ9307Injection, pralatrexate, 1 mgJ9308Injection, ramucirumab, 5 mgJ9309Injection, polatuzumab vedotin-piiq, 1 mgJ9311Injection, rituximab 10 mg and hyaluronidaseJ9312Injection, rituximab, 10 mgJ9313Injection, moxetumomab pasudotox-tdfk, 0.01 mgJ9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mgJ9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mgJ9317Injection, sacituzumab govitecan-hziy, 2.5 mgJ9318Injection, romidepsin, non-lyophilized, 0.1 mgJ9319Injection, romidepsin, lyophilized, 0.1 mgJ9320Injection, streptozocin, 1 gramJ9321Injection, epcoritamab-bysp, 0.16 mgJ9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mgJ9323Injection, pemetrexed ditromethamine, 10 mgJ9324Injection, pemetrexed (pemrydi rtu), 10 mgJ9325Injection, talimogene laherparepvec, per 1 million plaque forming unitsJ9326Injection, telisotuzumab vedotin-tllv, 1 mgJ9328Injection, temozolomide, 1 mgJ9329Injection, tislelizumab-jsgr, 1mgJ9330Injection, temsirolimus, 1 mgJ9331Injection, sirolimus protein-bound particles, 1 mgJ9332Injection, efgartigimod alfa-fcab, 2mgJ9333Injection, rozanolixizumab-noli, 1 mgJ9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfcJ9341Injection, thiotepa (tepylute), 1 mgJ9342Injection, thiotepa, not otherwise specified, 1 mgJ9345Injection, retifanlimab-dlwr, 1 mgJ9347Injection, tremelimumab-actl, 1 mgJ9348Injection, naxitamab-gqgk, 1 mgJ9349Injection, tafasitamab-cxix, 2 mgJ9350Injection, mosunetuzumab-axgb, 1 mgJ9351Injection, topotecan, 0.1 mgJ9353Injection, margetuximab-cmkb, 5 mgJ9354Injection, ado-trastuzumab emtansine, 1 mgJ9355Injection, trastuzumab, excludes biosimilar, 10 mgJ9356Injection, trastuzumab, 10 mg and hyaluronidase-oyskJ9357Injection, valrubicin, intravesical, 200 mgJ9358Injection, fam-trastuzumab deruxtecan-nxki, 1 mgJ9359Injection, loncastuximab tesirine-lpyl, 0.075 mgJ9360Injection, vinblastine sulfate, 1 mgJ9361Injection, efbemalenograstim alfa-vuxw, 0.5 mgJ9362Injection, trabectedin, 0.01 mgJ9370Vincristine sulfate, 1 mgJ9376Injection, pozelimab-bbfg, 1 mgJ9380Injection, teclistamab-cqyv, 0.5 mgJ9381Injection, teplizumab-mzwv, 5 mcgJ9382Injection, zenocutuzumab-zbco, 1 mgJ9390Injection, vinorelbine tartrate, 10 mgJ9393Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mgJ9394Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mgJ9395Injection, fulvestrant, 25 mgJ9400Injection, ziv-aflibercept, 1 mgJ9600Injection, porfimer sodium, 75 mgJ9601Injection, linvoseltamab-gcpt, 1 mgJ9999Not otherwise classified, antineoplastic drugs
Procedure codeCODABLE
J9050
Injection, carmustine, 100 mg
Part
HCPCS Level II
J
Drugs Administered Other than Oral Method
J9
J9000–J9999
Source

CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.